CMO Podnos Yale buys 9,056 shares of TOI at $1.04; 7 insiders bought in past 14 days as stock rallies +19.2% in 30 days from distressed $0.13 lows.
Podnos Yale, Chief Medical Officer, purchased 9,056 shares at $1.04 on 2025-03-26, increasing holdings by 12.9% to 79,049 shares. This purchase occurs within a cluster pattern of 7 other insiders buying within the past 14 days, suggesting coordinated or signal-driven accumulation at a pivotal moment. The stock is trading 30 days up +19.2% and 90 days up +260.2% from a 52-week low of $0.13, yet remains -38.0% below its 52-week high of $1.84. The company reported $99.9M in latest quarterly revenue with +21.3% annual growth, but remains unprofitable at $-16.1M net income, placing the near-$86.4M market cap in a high-risk, growth-stage profile. The convergence of insider cluster buying at an elevated price relative to recent lows, combined with fundamental losses despite revenue momentum, warrants monitoring of whether this reflects conviction or opportunism near a local peak.